News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Crypto Assets Cryptocurrency Investors Stock Shares Stock Market Ethereum Price Markets Xrp Investment Blockchain Sec Etf Stablecoin Eth Trade Earnings Index Bse Revenue Solana Ipo China Coinbase Token Wall Street Nasdaq Inflation Interest Rates Trade War Usd Sensex Economy Tesla Profit Digital Assets Nse Sp 500 Traders Gold Treasury Nvidia Federal Reserve Electric Vehicles Dca Succinct Deloitte Asset Preservation United Arab Emirates Study Visas Crypto Perpetual Futures Multisig Trust Btcs Inc

Filter by:

Rsv × CNBC Business ×

CNBC Business • Jun 09, 2025

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...

Read Full Article →